Mariaelena Casagrande

949 total citations
21 papers, 123 citations indexed

About

Mariaelena Casagrande is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Mariaelena Casagrande has authored 21 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mariaelena Casagrande's work include Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Genetic factors in colorectal cancer (5 papers). Mariaelena Casagrande is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Genetic factors in colorectal cancer (5 papers). Mariaelena Casagrande collaborates with scholars based in Italy, United States and Ukraine. Mariaelena Casagrande's co-authors include Giuseppe Aprile, Gianpiero Fasola, Caterina Fontanella, Chiara Cremolini, Stefano Pizzolitto, Karim Rihawi, Giovanna De Maglio, Francesco Tuniz, Federica Pisa and Stefania Eufemia Lutrino and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Mariaelena Casagrande

20 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariaelena Casagrande Italy 8 91 45 37 22 19 21 123
Sherif Raouf United Kingdom 8 82 0.9× 46 1.0× 21 0.6× 10 0.5× 9 0.5× 13 111
Chengyou Du China 7 64 0.7× 54 1.2× 45 1.2× 13 0.6× 28 1.5× 11 107
Caterina Accettura Italy 7 104 1.1× 40 0.9× 35 0.9× 27 1.2× 42 2.2× 14 170
Juana María Cano Spain 8 82 0.9× 40 0.9× 23 0.6× 39 1.8× 10 0.5× 25 136
Tetsuji Terazawa Japan 9 96 1.1× 84 1.9× 39 1.1× 29 1.3× 15 0.8× 41 169
Yakup Ergün Türkiye 7 122 1.3× 58 1.3× 24 0.6× 20 0.9× 12 0.6× 44 181
Effie Skrinos Australia 4 109 1.2× 55 1.2× 44 1.2× 35 1.6× 9 0.5× 8 151
Jan‐Willem B. de Groot Netherlands 8 111 1.2× 36 0.8× 35 0.9× 20 0.9× 7 0.4× 12 183
N. Zanaletti Italy 8 133 1.5× 35 0.8× 45 1.2× 37 1.7× 10 0.5× 20 156
Hirokazu Mizuguchi United States 7 92 1.0× 57 1.3× 25 0.7× 34 1.5× 20 1.1× 11 145

Countries citing papers authored by Mariaelena Casagrande

Since Specialization
Citations

This map shows the geographic impact of Mariaelena Casagrande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariaelena Casagrande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariaelena Casagrande more than expected).

Fields of papers citing papers by Mariaelena Casagrande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariaelena Casagrande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariaelena Casagrande. The network helps show where Mariaelena Casagrande may publish in the future.

Co-authorship network of co-authors of Mariaelena Casagrande

This figure shows the co-authorship network connecting the top 25 collaborators of Mariaelena Casagrande. A scholar is included among the top collaborators of Mariaelena Casagrande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariaelena Casagrande. Mariaelena Casagrande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fanotto, V., Daniele Rossini, Mariaelena Casagrande, et al.. (2023). Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies. Cancers. 15(22). 5451–5451. 1 indexed citations
2.
Nardo, Paola Di, Debora Basile, Ana Paula dos Reis Velloso Siciliano, et al.. (2023). Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA). Digestive and Liver Disease. 56(5). 786–794.
3.
Prete, Alessandra Anna, Paolo Manca, Federica Morano, et al.. (2022). Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study.. Journal of Clinical Oncology. 40(4_suppl). 5–5. 1 indexed citations
4.
Lisanti, C., Debora Basile, Silvio Ken Garattini, et al.. (2022). The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer. Cancers. 15(1). 175–175. 9 indexed citations
5.
6.
Lonardi, Sara, Filippo Pietrantonio, Alessandra Anna Prete, et al.. (2020). Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment: The CARACAS study.. Journal of Clinical Oncology. 38(15_suppl). 4051–4051. 1 indexed citations
7.
Lisanti, C., Debora Basile, Elisa Bertoli, et al.. (2020). The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer. Journal of Geriatric Oncology. 11(8). 1268–1273. 9 indexed citations
8.
Garattini, Silvio Ken, Marta Bonotto, Luca Porcu, et al.. (2020). Determinants of Choice in Offering Drug Holidays During First-Line Therapy for Metastatic Colorectal Cancer. Future Oncology. 16(32). 2645–2660. 1 indexed citations
9.
Moretto, Roberto, Federica Morano, Elena Ongaro, et al.. (2019). Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component. Clinical Colorectal Cancer. 18(2). 116–124. 7 indexed citations
10.
11.
Aprile, Giuseppe, Mariaelena Casagrande, Giovanna De Maglio, et al.. (2016). Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology. 13(2). 135–144. 10 indexed citations
12.
Maglio, Giovanna De, Mariaelena Casagrande, Michela Guardascione, et al.. (2015). MGMT Promoter Methylation Status in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors. Future Oncology. 11(8). 1201–1209. 11 indexed citations
13.
Aprile, Giuseppe, Francesco Leone, Mariaelena Casagrande, et al.. (2015). Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology. OncoTargets and Therapy. 8. 1149–1149. 4 indexed citations
14.
Aprile, Giuseppe, Caterina Fontanella, Marta Bonotto, et al.. (2015). Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials. Oncotarget. 6(30). 28716–28730. 10 indexed citations
15.
Casagrande, Mariaelena, Karim Rihawi, Caterina Fontanella, et al.. (2015). 2153 Analysis ofthe molecular profile of brain metastases from colorectal cancer and concordance with matched primary tumors. European Journal of Cancer. 51. S384–S385. 1 indexed citations
16.
Bergamo, Francesca, Marta Schirripa, Fotios Loupakis, et al.. (2014). BRAF and KRAS mutations in liver-resected metastatic colorectal cancer (mCRC) patients (pts).. Journal of Clinical Oncology. 32(3_suppl). 476–476. 1 indexed citations
17.
Cremolini, Chiara, Fotios Loupakis, Lisa Salvatore, et al.. (2014). Modified FOLFOXIRI plus cetuximab (cet) as induction treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Preliminary results of the phase II randomized Macbeth trial by GONO group.. Journal of Clinical Oncology. 32(15_suppl). 3596–3596. 5 indexed citations
18.
Aprile, Giuseppe, Giovanna De Maglio, Jessica Menis, et al.. (2013). HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series. International Journal of Molecular Sciences. 14(2). 2370–2387. 15 indexed citations
19.
Casagrande, Mariaelena, Chiara Cremolini, Fotios Loupakis, & Giuseppe Aprile. (2013). A Perspective on the Current Management of Advanced Colorectal Cancer. Future Oncology. 9(11). 1687–1691. 6 indexed citations
20.
D’Amato, Andrea, et al.. (1998). End to side mucomucosal Wirsung jejunostomy after pancreaticoduodenectomy: immediate results and long term follow-up.. PubMed. 45(22). 1135–40. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherif Raouf Breakdown of academic impact, for papers by Chengyou Du Breakdown of academic impact, for papers by Caterina Accettura Breakdown of academic impact, for papers by Juana María Cano Breakdown of academic impact, for papers by Tetsuji Terazawa Breakdown of academic impact, for papers by Yakup Ergün Breakdown of academic impact, for papers by Effie Skrinos Breakdown of academic impact, for papers by Jan‐Willem B. de Groot Breakdown of academic impact, for papers by N. Zanaletti Breakdown of academic impact, for papers by Hirokazu Mizuguchi
Rankless by CCL
2026